Michael A. Davis has been elected as Chairman of the Board of Directors
of Cyanotech Corporation (Nasdaq Capital Market: CYAN). He replaces
Gregg Robertson, who resigned in late 2010.
Mr. Davis was Vice-Chairman of the Board and has been a Director of
Cyanotech since March 2003.
"Michael has been a key influence in helping Cyanotech sharpen its
business model and market focus in recent years," said Brent Bailey,
President and CEO. "We look forward to his continuing support and
leadership as Chairman of the Board."
Mr. Davis, a private Investor and major shareholder of Cyanotech since
1994, is also President of Skywords Family Foundation and a Director of
Canobie Films, Inc.
About Cyanotech -- Cyanotech Corporation, a world leader in
microalgae technology, produces BioAstin® Natural Astaxanthin and
Hawaiian Spirulina Pacifica®--all natural, functional nutrients
that leverage our experience and reputation for quality, building
nutritional brands which promote health and well-being. Cyanotech's
Spirulina products offer complete nutrition, and augment energy and
immune response. They are FDA reviewed and accepted as Generally
Recognized as Safe (GRAS) for use in food products. BioAstin's superior
antioxidant activity and ability to support and maintain a natural
anti-inflammatory response enhance skin, muscle and joint health. All
Cyanotech products are produced from microalgae grown at its 90-acre
facility in Kona, Hawaii using patented and proprietary technology.
Cyanotech distributes to nutritional supplement, nutraceutical and
cosmeceutical manufacturers and marketers in more than 54 countries
worldwide. Cyanotech was the first microalgae company in the
world to obtain quality management standards ISO 9001:2000 certification
and is GMP-certified by the Natural Products AssociationTM.
for more information.
Bruce Russell, 310-559-4955 x101